|
Sources:The
back crusts and whole body of Trionyx sinensis (Wiegmann)
Family Trionychidae.
Constituents:
Containing collagen, peptide, amino acids, polysacchari- des,
etc.
Actions: The nude
mice were divided into two groups, the therapeutic group was
intragastral perfusion with the powder of Trionyx at a dose
of 800 mg/kg. d for two weeks, then the nude mice were implanted
with the cells of human intestinal cancer, and continued to
give the drug for 35 days (the control group was given placebo),
the inhibitory rate was 92.15%.
In addition, the mice was dieted
the polysaccharide of Trionyx at the dose of 1g/kg. d for
7 days, then the mice were implanted the cells of B16 or FBL
3 (erythroleukemia), and successively to given polysaccharide.
The results showed that the survival period of control group
were 24.5 days (B16) and
25.2 days (FBL-3) respectively, while the therapeutic group
were 44.1 days (B16) and 37.8 days (FBL-3) respectively.
Indications:Composite
prescription for breast cancer:
Carapax Trionycis Preparata 12g
Squama Manitis 12g
Spica Prunellae 30g
Sargassum 30g
Fructus seu Semen Cassiae 30g
Occidentalis
flos Chrysanthemi Indici 30g
Herba Hedyotis Diffuse 30g
Herba Solani Lyrati 30g
Radix Salviae Miltiorrhizae 30g
Fructus Trichosanthis 30g
Concha Ostreae 30g
Thallus Echloniae 15g
Rhizoma Dioscoreae 15g
Radix Adenophorae 12g
Semen Vaccariae 12g
Nidus Vespae 12g
Semen Persicae 9g
The above herbs were decocted for oral
administration combined with Xiao Jin Wan 10 pills. The prescription
was used to treat 11 cases of breast cancer. The results showed
that clinical cure in1 cases, remarkable effect in 2 cases,
efficacy in 6 cases, the total effective rate was 81.8%, and
survived for 5 years, 6 years and 8 years was 1 case in each
respectively.
|
.jpg)